Tobira Therapeutics, Inc. (NASDAQ:TBRA) Reveals CENTAUR Didn’t Meet Study Endpoint
Tobira Therapeutics, Inc. (NASDAQ:TBRA) has finally revealed on Monday the results of the Phase 2b safety and efficacy clinical trial for cenicriviroc (CVC) treating non-alcoholic […]